Recruiting now
-
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Phase 1 · 307 people · 26 sites in 5 countries · Recruiting now
-
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Phase 1 · 200 people · 5 sites in United States · Recruiting now
-
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
Phase 2 · 12 people · 1 site in Germany · Recruiting now
-
A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors
Phase 1 · 115 people · 2 sites in Australia · Recruiting now
-
MAP- Versus Cardiac Index-Guided Hemodynamic Management in Colorectal Surgery
Not phased · randomised · 60 people · 1 site in Turkey (Türkiye) · Recruiting now
-
Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer
Phase 2 · 20 people · 1 site in China · Recruiting now
-
Total Neoadjuvant Therapy in Rectal Cancer
Phase 2 · 42 people · 1 site in Taiwan · Recruiting now
-
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
Phase 2 · 51 people · 1 site in China · Recruiting now
-
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
Phase 2 · 35 people · 1 site in China · Recruiting now